N-cadherin expression is a potential survival mechanism of gefitinib-resistant lung cancer cells

Non-small cell lung cancer (NSCLC) is a major subtype of lung cancer and is the most common and fatal cancer worldwide. Specific tyrosine kinase inhibitors for epidermal growth factor receptor (EGFR), such as gefitinib, have been effective in some NSCLC patients and are being used in the clinical se...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yamauchi, Mai, Yoshino, Ikuyo, Yamaguchi, Rui, Shimamura, Teppei, Nagasaki, Masao, Imoto, Seiya, Niida, Atsushi, Koizumi, Fumiaki, Kohno, Takashi, Yokota, Jun, Miyano, Satoru, Gotoh, Noriko
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3196281/
https://ncbi.nlm.nih.gov/pubmed/22016830
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars